Keyphrases
Mouse Model
100%
Multiple Mechanisms
100%
Neuroprotective Effect
100%
Cilostazol
100%
Permanent Focal Ischemia
100%
Ischemia
45%
Immunohistochemistry
27%
CAMP Response Element-binding Protein
27%
Oxidative Stress
18%
8-hydroxydeoxyguanosine (8-OHdG)
18%
Infarct Volume
18%
Boundary Region
18%
NADPH Oxidase 2 (NOX2)
18%
Transient Middle Cerebral Artery Occlusion (tMCAO)
9%
Tissue Damage
9%
Protein Pathway
9%
Anti-apoptosis
9%
Brain Section
9%
Ischemic Brain Injury
9%
Multiple Mechanisms of Action
9%
Antiplatelet Drugs
9%
Phosphodiesterase 3 Inhibitor
9%
Ischemic Tissue
9%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Neuroprotective Agent
100%
Ischemia
100%
Cilostazol
100%
Cyclic AMP Responsive Element Binding Protein
27%
Infarction
18%
Tissue Injury
9%
Antiapoptotic
9%
8 Hydroxydeoxyguanosine
9%
Phosphodiesterase III Inhibitor
9%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2
9%
Brain Injury
9%
Middle Cerebral Artery Occlusion
9%
Antithrombocytic Agent
9%
Neuroscience
Neuroprotective Agent
100%
Cilostazol
100%
Ischemia
100%
Immunohistochemistry
27%
Cyclic AMP Responsive Element Binding Protein
27%
Oxidative Stress
18%
Middle Cerebral Artery
9%
8 Hydroxydeoxyguanosine
9%
Antiplatelet Drug
9%
PDE3 Inhibitor
9%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2
9%